Tablet Hardness Testers for Brazil's Growing Pharmaceutical Sector
Brazil's pharmaceutical manufacturers operate under one of the most demanding quality frameworks in Latin America. ANVISA, the national health surveillance authority, requires documented in-process quality control at every stage of solid dosage production. When tablet hardness drifts outside specification, the consequences range from failed batch release to regulatory findings during GMP inspection.
A tablet hardness tester in Brazil gives quality laboratories and production teams the breaking force data they need to detect compression problems early, satisfy ANVISA documentation requirements, and maintain consistent performance across high-volume batch runs. Torontech supplies a complete range of tablet hardness testers built for pharmaceutical environments where traceability and audit readiness are mandatory.
Brazil's Solid Dose Manufacturing Boom
Brazil is the largest pharmaceutical market in Latin America, with revenues surpassing US $36 billion in 2025. The domestic manufacturing base is concentrated in São Paulo state and the Anápolis industrial corridor in Goiás. Domestic giants including EMS, Hypera Pharma, Eurofarma, and Aché operate at substantial scale. Hypera's flagship complex in Anápolis alone produces more than 650 million solid doses annually from a single facility, requiring consistent tablet hardness monitoring across hundreds of production runs.
Government investment in local pharmaceutical manufacturing reinforces this growth. In mid-2024, BNDES (Brazil's National Development Bank) approved US $270 million in credit for the pharmaceutical and pharma-chemical industries, the highest credit volume since 1995. As manufacturing capacity expands, the demand for reliable testing instruments intensifies.
Generic drugs account for approximately 38% of the Brazilian pharmaceutical market by volume. This creates a high-throughput testing environment where in-process quality control (IPQC) at the press is standard practice and hardness data must appear in the production record for every batch released under ANVISA's GMP framework.
ANVISA, cGMP, and the Farmacopeia Brasileira
ANVISA enforces pharmaceutical manufacturing quality through RDC 658/2022 and supporting regulations, all aligned with the PIC/S guide and the ICH Q10 pharmaceutical quality system. Equipment used in Brazilian pharmaceutical quality control laboratories must be calibrated, performance-verified, and qualified under documented IQ and OQ procedures. Inspection findings related to calibration gaps or missing validation records are among the most common deficiencies identified in ANVISA GMP audits.
The Farmacopeia Brasileira (7th edition, approved by ANVISA in 2024) is the official compendium for pharmaceutical testing methods in Brazil. Its tablet hardness test methods are harmonized with USP <1217> (Tablet Breaking Force) and Ph. Eur. 2.9.8. Manufacturers conducting hardness testing to USP <1217> protocols therefore apply diametral compression methods directly aligned with Farmacopeia Brasileira specifications.
Torontech's ToronEHT™ and ToronTAB™ series are built on stainless steel cGMP-compliant frames, support USP <1217> and Ph. Eur. 2.9.8 test protocols, and ship with IQ/OQ validation documentation. These features directly address the equipment qualification requirements that ANVISA GMP inspectors evaluate during site inspections.
Torontech's Tablet Hardness Tester Range for Brazilian Facilities
Torontech offers a tiered lineup that covers every application in a Brazilian pharmaceutical facility, from quick in-process hardness checks at the tablet press to comprehensive 5-parameter batch release testing in the quality control laboratory.
| Model | Parameters | Hardness Range | Capacity | Standout Capability |
|---|---|---|---|---|
| ToronEHT™ (New Generation) | 5 | 0–800 N | Up to 200 tablets | Next-gen constant-speed design, 7" touchscreen, 50,000-report storage |
| ToronTAB™ 5 (Tab Series) | 5 | 3–800 N | Up to 1000 tablets | Tilt sensing device, multilingual interface, IQ/OQ documents |
| EHT-5PR (Tab Series) | 5 | 3–800 N | Up to 1000 tablets | 21 CFR Part 11 compliance, embedded printer, full audit trail |
| Portable (ToronPTAB™) | 1 | USP compliant | Per sample | On-floor IPQC, compact design, auto unit conversion (N/kP/SC) |
All 5-parameter models measure weight, hardness, thickness, diameter/length, and width simultaneously, giving quality teams a complete dimensional and mechanical profile of each tablet in a single test. The portable series is suited to spot checks directly at the press or in satellite quality stations throughout the production floor.
Critical Features for Selecting a Tablet Hardness Tester in Brazil
Quality control managers sourcing a tablet hardness tester in Brazil typically assess instruments across five operational requirements:
- Hardness range and repeatability: A 3 to 800 N range covers standard film-coated tablets through specialized extended-release formulations. A repeatability of ±1 N ensures breaking force data lands within USP <1217> acceptance criteria without ambiguity.
- Data integrity and user security: Multi-level user management supporting up to 10 configurable roles, password-protected access, and 21 CFR Part 11-compliant electronic records support the data integrity expectations that ANVISA documents during inspections.
- Calibration and validation support: Two-point calibration with three-point linearity verification, combined with available IQ/OQ documentation, supports the full equipment qualification lifecycle required under ANVISA's GMP framework and PIC/S-aligned quality systems.
- External balance integration: Direct connectivity with Sartorius, Mettler Toledo, Shimadzu, Contech, and Ohaus balances brings weight measurement into the same 5-parameter test workflow, eliminating a separate data entry step that introduces transcription risk.
- Throughput capacity: Systems capable of processing up to 1000 tablets per test cycle match the demands of high-volume batch release operations at major solid dose manufacturers, where testing must keep pace with production output.
Equip Your Facility with a Reliable Tablet Hardness Tester in Brazil
Brazil's pharmaceutical sector is expanding rapidly, and ANVISA's GMP inspection program is tightening in parallel. Quality laboratories cannot afford instruments that produce inconsistent breaking force readings, lack calibration traceability, or fail to generate the electronic records auditors expect. The documentation gap is where GMP deficiencies accumulate.
Torontech serves pharmaceutical manufacturers across Latin America with tested instrumentation, full validation documentation, and technical support configured for cGMP production environments. Whether your facility runs a high-throughput batch release laboratory requiring a 5-parameter system or a production floor where portable in-process checks are the first line of quality defense, the Torontech tablet hardness tester range has a configuration for your application.
To receive a product recommendation and discuss your testing requirements, contact the Torontech team for a consultation on equipping your Brazilian operation.
